Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Small intestine cancer
Stage/Subtype:  recurrent small intestine cancer
Country:  U.S.A.
Trial Type:  Treatment
Results 1-4 of 4 for your search:
Start Over
Panitumumab in Treating Patients with Locally Advanced or Metastatic Small Intestine or Ampulla of Vater Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0458, NCI-2012-01894, NCI-2010-02085, NCT01202409
Ganetespib and Ziv-Aflibercept in Treating Patients with Refractory or Metastatic Gastrointestinal Cancer, Non-small Cell Lung Cancer, Urothelial Cancer, or Sarcoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Age: 18 and over
Trial IDs: 9605, NCI-2014-00626, 09-25-0099, 141525, 14-C-0150, P141525, NCT02192541
Alisertib and Combination Chemotherapy in Treating Patients with Gastrointestinal Tumors
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: VICC GI1536, NCI-2014-02475, 9824, NCT02319018
Ropidoxuridine in Treating Patients with Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BrUOG 265, NCI-2015-00258, 9882, NCT02381561
Start Over